Commission Delegated Regulation (EU) 2026/133 of 20 January 2026 amending Delegated Regulation (EU) 2020/688 as regards rules for the movement within the Union of kept dogs, cats and ferrets, and other carnivores

Type Delegated Regulation
Publication 2026-03-27
State In force
Text As published
Department European Commission, SANTE
Source EUR-Lex
articles 2

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API
Image omitted; see official source Official Journal of the European Union EN L series
--- --- ---
2026/133 27.3.2026

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) [^ntr1-L_202600133EN.000101-E0001], and in particular the second subparagraph of Article 3(5), Article 136(2) and Article 140, point (a)(i) thereof,

Whereas:

HAS ADOPTED THIS REGULATION:

Article 1

Amendments to Delegated Regulation (EU) 2020/688

Delegated Regulation (EU) 2020/688 is amended as follows:

‘Article 53

Requirements for the movement of dogs, cats and ferrets to other Member States

Operators shall only move dogs, cats and ferrets to another Member State when the following requirements are fulfilled:

  • (a) the animals are individually identified:

either

  • (i) by an injectable transponder implanted in accordance with Article 70 of Delegated Regulation (EU) 2019/2035 and complying with the requirements laid down in Article 70a of that Delegated Regulation;

or

  • (ii) by a clearly readable tattoo applied before 3 July 2011;
  • (b) the animals come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the 30 days prior to the date of dispatch;
  • (c) the animals have received a complete primary course of anti-rabies vaccination at least 21 days prior to the date of movement, or have been re-vaccinated against rabies, in accordance with the validity requirements set out in Part 1 of Annex VII; however, this requirement shall not apply to dogs, cats and ferrets moved in accordance with Article 54(1) and (2);
  • (d) in the case of dogs moved to a Member State or zone thereof with a disease-free status from infestation with Echinococcus multilocularis, they have been subjected to the risk-mitigation measures for infestation with Echinococcus multilocularis in accordance with Part 2(1) of Annex VII within the required period set out in Part 2(2) of that Annex, prior to entering that Member State or zone; however, this requirement shall not apply to dogs moved in accordance with Article 54(2);
  • (e) the animals are individually accompanied by an identification document provided for in Article 71(1) of Delegated Regulation (EU) 2019/2035, which documents and certifies compliance with the requirements laid down in points (c) and (d);
  • (f) animals that are assembled after leaving their establishment of origin, are assembled in assembly centres of dogs, cats and ferrets approved in accordance with Article 10 of Delegated Regulation (EU) 2019/2035.’

;

  • ‘(i) by an injectable transponder implanted in accordance with Article 70 of Delegated Regulation (EU) 2019/2035 and complying with the requirements laid down in Article 70a of that Delegated Regulation;’;
  • ‘(b) the animals are each accompanied by an individual identification document referred to in Article 71(1) of Delegated Regulation (EU) 2019/2035 which documents that:
  • (i) each animal has received a complete primary course of anti-rabies vaccination at least 21 days prior to the date of movement, or has been re-vaccinated against rabies, in accordance with the validity requirements set out in Part 1 of Annex VII; however, this requirement shall not apply to dogs, cats and ferrets moved in accordance with Article 56;
  • (ii) in the case of dogs moved to a Member State or zone thereof with a disease-free status from Echinococcus multilocularis, they have been subjected to the risk-mitigation measures for infestation with Echinococcus multilocularis in accordance with Part 2(1) of Annex VII within the required period set out in Part 2(2) of that Annex, prior to entering that Member State or zone.’;
  • ‘(d) in the case of canidae moved to a Member State or zone thereof with a disease-free status from Echinococcus multilocularis, the animals have been subjected to the risk-mitigation measures for infestation with Echinococcus multilocularis in accordance with Part 2(3) of Annex VII to this Regulation within the required period set out in that Part, prior to entering that Member State or zone;’;
  • ‘(i) the individual identification document for each dog, cat and ferret to be moved, as referred to in Article 71(1) of Delegated Regulation (EU) 2019/2035, is duly completed with the information referred to in Article 53, points (b), (c) and (d) of this Regulation;’;

‘1.   Operators, or where applicable pet keepers, shall only move captive birds except racing pigeons to sporting events, honeybees, bumble bees except bumble bees from approved environmentally isolated production establishments, primates, dogs, cats, ferrets or other carnivores to another Member State if they are accompanied by an animal health certificate issued by the competent authority of the Member State of origin.’

;

Article 2

Entry into force and application

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.

It shall apply from 22 April 2026.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 20 January 2026.

For the Commission

The President

Ursula VON DER LEYEN

[^ntr1-L_202600133EN.000101-E0001]: OJ L 84, 31.3.2016, p. 1, ELI: http://data.europa.eu/eli/reg/2016/429/oj.

[^ntr2-L_202600133EN.000101-E0002]: Commission Delegated Regulation (EU) 2020/688 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council, as regards animal health requirements for movements within the Union of terrestrial animals and hatching eggs (OJ L 174, 3.6.2020, p. 140, ELI: http://data.europa.eu/eli/reg_del/2020/688/oj).

[^ntr3-L_202600133EN.000101-E0003]: Commission Delegated Regulation (EU) 2019/2035 of 28 June 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for establishments keeping terrestrial animals and hatcheries, and the traceability of certain kept terrestrial animals and hatching eggs (OJ L 314, 5.12.2019, p. 115, ELI: http://data.europa.eu/eli/reg_del/2019/2035/oj).

[^ntr4-L_202600133EN.000101-E0004]: Regulation (EU) No 576/2013 of the European Parliament and of the Council of 12 June 2013 on the non-commercial movement of pet animals and repealing Regulation (EC) No 998/2003 (OJ L 178, 28.6.2013, p. 1, ELI: http://data.europa.eu/eli/reg/2013/576/oj).

[^ntr5-L_202600133EN.000101-E0005]: Commission Delegated Regulation (EU) 2018/772 of 21 November 2017 supplementing Regulation (EU) No 576/2013 of the European Parliament and of the Council with regard to preventive health measures for the control of Echinococcus multilocularis infection in dogs, and repealing Delegated Regulation (EU) No 1152/2011 (OJ L 130, 28.5.2018, p. 1, ELI: http://data.europa.eu/eli/reg_del/2018/772/oj).

[^ntr6-L_202600133EN.000101-E0006]: Commission Implementing Regulation (EU) 2018/878 of 18 June 2018 adopting the list of Member States, or parts of the territory of Member States, that comply with the rules for categorisation laid down in Article 2(2) and (3) of Delegated Regulation (EU) 2018/772 concerning the application of preventive health measures for the control of Echinococcus multilocularis infection in dogs (OJ L 155, 19.6.2018, p. 1, ELI: http://data.europa.eu/eli/reg_impl/2018/878/oj).

[^ntr7-L_202600133EN.000101-E0007]: Commission Delegated Regulation (EU) 2026/132 of 20 January 2026 amending Delegated Regulation (EU) 2019/2035 as regards rules for the traceability of kept dogs, cats and ferrets (OJ L, 2026/132, 27.3.2026, ELI: http://data.europa.eu/eli/reg_del/2026/132/oj).

ANNEX

‘ANNEX VII

VALIDITY REQUIREMENTS FOR ANTI-RABIES VACCINATION AND RISK-MITIGATING MEASURES FOR DISEASES OTHER THAN RABIES

Part 1

Validity requirements for anti-rabies vaccinations for dogs, cats, ferrets and other carnivores

1. The anti-rabies vaccine shall comply with the following requirements: (a) it must be a vaccine other than a live modified vaccine, and fall within one of the following categories: (i) an inactivated vaccine of at least one antigenic unit per dose; or (ii) a recombinant vaccine expressing the immunising glycoprotein of the rabies virus in a live virus vector; (b) where it is administered: (i) in a Member State, it has been granted a marketing authorisation in compliance with Regulation (EU) 2019/6 of the European Parliament and of the Council [^ntr1-L_202600133EN.000502-E0001]; or (ii) in a third country or territory, it has been granted an approval or a licence by the competent authority and it meets at least the requirements laid down in the relevant part of the chapter concerning rabies in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health (WOAH).
--- --- ---
2. An anti-rabies vaccination shall fulfil the following conditions: (a) the vaccine has been administered by an official veterinarian or an authorised veterinarian as defined in Article 2(1) of Commission Delegated Regulation (EU) 2026/131 [^ntr2-L_202600133EN.000502-E0002], as decided by the competent authority; (b) the animal was at least 12 weeks old at the time of the primary vaccination; (c) the date of administration of the vaccine is indicated by a veterinarian referred to in point (a), in the appropriate section of the identification document referred to in Article 71(1) of Delegated Regulation (EU) 2019/2035; (d) the date of administration referred to in point (c) does not precede the date of identification or the date of reading of the identification means indicated in the appropriate section of the identification document referred to in Article 71(1) of Delegated Regulation (EU) 2019/2035; (e) the period of validity of the vaccination starts from the establishment of protective immunity, which shall not be less than 21 days from the completion of the vaccination protocol required by the manufacturer for the primary vaccination, and continues until the end of the period of protective immunity, as prescribed in the technical specifications of the marketing authorisation referred to in point 1(b)(i), or the approval or licence referred to in point 1(b)(ii) for the anti-rabies vaccine in the Member State or third country or territory where the vaccine is administered. The period of validity of the vaccination shall be indicated by a veterinarian referred to in point (a) in the appropriate section of the identification document referred to in Article 71(1) of Delegated Regulation (EU) 2019/2035; (f) a revaccination must be considered a primary vaccination if it was not carried out within the period of validity referred to in point (e) of the previous vaccination.

Part 2

Risk-mitigating measures for infestation with Echinococcus multilocularis

1. The treatment for infestation with Echinococcus multilocularis referred to in Article 53, point (d), and Article 55, point (b)(ii), shall be administered by a veterinarian and shall consist of a veterinary medicinal product: (a) which contains the appropriate dose of: (i) praziquantel; or (ii) other pharmacologically active substances, which alone or in combination, have proven to reduce the burden of mature and immature intestinal forms of Echinococcus multilocularis in dogs at least as effectively as praziquantel; and (b) which has been granted either: (i) a marketing authorisation in compliance with Regulation (EU) 2019/6 of the European Parliament and of the Council; or (ii) an approval or a licence by the competent authority in a third country.
--- --- ---
2. The treatment referred to in point 1 shall have been administered within a period commencing not more than 120 hours and ending not less than 24 hours prior to the date of the scheduled entry into a Member State or zone thereof with a disease-free status from Echinococcus multilocularis.
--- --- ---
3. For canidae other than dogs, the treatment referred to in Article 58(1), point (d), against infestation with Echinococcus multilocularis shall consist of a veterinary medicinal product referred to in point 1 and shall have been carried out no earlier than 48 hours prior to entry into a Member State or zone thereof with a disease-free status from Echinococcus multilocularis.

’

[^ntr1-L_202600133EN.000502-E0001]: Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (OJ L 4, 7.1.2019, p. 43, ELI: http://data.europa.eu/eli/reg/2019/6/oj).

[^ntr2-L_202600133EN.000502-E0002]: Commission Delegated Regulation (EU) 2026/131 of 20 January 2026 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council, as regards animal health requirements for non-commercial movement of pet animals (OJ L, 2026/131, 27.3.2026, ELI: http://data.europa.eu/eli/reg_del/2026/131/oj).

ELI: http://data.europa.eu/eli/reg_del/2026/133/oj

ISSN 1977-0677 (electronic edition)

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.